Exploratory Study of Danicamtiv in Patients With Primary Dilated Cardiomyopathy (DCM) Due to Genetic Variants or Other Causalities
Clinical trial NCT04572893 · TERMINATED
Trial details
- NCT number
- NCT04572893
- Sponsor
- Bristol-Myers Squibb
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-04
- Primary completion
- 2024-02-22
- Enrollment
- 41
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.